Instadose Pharma's total assets for Q1 2022 were $45.94M, an increase of Infinity% from the previous quarter. INSD total liabilities were $10.28M for the fiscal quarter, a 4871.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.